Evidence map›Paper›PMID 38463495›Full record

ArticleACG case reports journal2024

Autoimmune Hepatitis on a Living Liver Donor: An Unexpected Long-Term Complication.

Bernardo Canhão, Augusta Cipriano, Armando Carvalho, Adélia Simão, João Madaleno

Abstract readCase Reports
In one paragraph

Article in ACG case reports journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bernardo CanhãoLiver Disease Unit-Internal Medicine Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Augusta CiprianoPathology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Armando CarvalhoLiver Disease Unit-Internal Medicine Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Adélia SimãoLiver Disease Unit-Internal Medicine Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
João MadalenoLiver Disease Unit-Internal Medicine Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-5547-9424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Western countries, deceased donor liver transplantation remains the standard of care for patients with end-stage liver disease. Living donor liver transplantation is a viable and feasible strategy for patients with end-stage liver disease designed to mitigate the deceased organ shortage. Donor safety is the primary concern because liver donors, ideally, should not have any complication. We report a case of middle-aged woman without a history of chronic liver disease who developed autoimmune hepatitis more than 20 years after live liver donation. Changes in these patients' liver enzymes should prompt swift referral to an hepatologist for initial liver disease work-up.

Indexed as

autoimmune hepatitisliver transplantationliving liver donors

Identifiers

PMID38463495
PMCPMC10923377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.